CG
LLY icon

Cynosure Group’s Eli Lilly LLY Stock Holding History

Cynosure Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
+220
New +$225K 0.04% 168
2026
Q1 		– Sell
-557
Closed -$599K – 347
2025
Q4 		$599K Sell
557
-804
-59% -$769K 0.06% 111
2025
Q3 		$1.04M Sell
1,361
-673
-33% -$501K 0.11% 72
2025
Q2 		$1.59M Buy
2,034
+367
+22% +$285K 0.18% 58
2025
Q1 		$1.38M Buy
1,667
+107
+7% +$89K 0.19% 57
2024
Q4 		$1.2M Sell
1,560
-562
-26% -$465K 0.18% 63
2024
Q3 		$1.88M Buy
2,122
+379
+22% +$341K 0.27% 47
2024
Q2 		$1.58M Buy
1,743
+16
+0.9% +$12.8K 0.25% 56
2024
Q1 		$1.34M Buy
1,727
+775
+81% +$552K 0.24% 49
2023
Q4 		$555K Buy
952
+64
+7% +$37.4K 0.1% 116
2023
Q3 		$477K Buy
+888
New +$458K 0.15% 111

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cynosure Group's LLY Position: Q2 2026 in Review

Cynosure Group opened a new position in Eli Lilly (LLY) in Q2 2026: 220 shares worth $264K. The stake represents 0.04% of the portfolio and ranks #168 among its holdings. This is a return to the name: Cynosure Group previously reported a position in LLY as recently as Q4 2025.

Cynosure Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.88M in Q3 2024. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cynosure Group held 220 shares of Eli Lilly worth $264K as of Q2 2026.
  • Eli Lilly was a new Cynosure Group position in Q2 2026.
  • Eli Lilly made up 0.04% of Cynosure Group's portfolio in Q2 2026, its #168 holding.
  • Cynosure Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Cynosure Group's Eli Lilly position peaked at $1.88M in Q3 2024.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.